Clinical characteristics and prognostic factors for primary appendiceal carcinoma

Asia-Pacific Journal of Clinical Oncology

Volumn 6, Issue 1, 2010, Pages 19-27

  Ko, Yoon Ho ^a   Park, Se Hoon ^b   Jung, Chan Kwon ^c   Won, Hye Sung ^a   Hong, Sook Hee ^a   Park, Ji Chan ^a   Roh, Sang Young ^a   Woo, In Sook ^a   Kang, Jin Hyoung ^a   Hong, Young Seon ^a   Byun, Jae Ho ^a  

^a The Catholic University of Korea   (South Korea)

^b Samsung Medical Center   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

Appendix; Carcinoma; Prognosis

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ABDOMINAL PAIN; ADULT; ADVANCED CANCER; AGED; APPENDECTOMY; APPENDIX CARCINOMA; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; COLLOID CARCINOMA; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; EMERGENCY SURGERY; FEMALE; FOLLOW UP; GASTROINTESTINAL CARCINOMA; HEMICOLECTOMY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PERITONEUM METASTASIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; RECURRENT CANCER; REGIONAL METASTASIS; RETROSPECTIVE STUDY; RISK REDUCTION; SEX DIFFERENCE; SIGNET RING CARCINOMA; SOUTH KOREA; SURVIVAL RATE; SURVIVAL TIME; TUMOR LOCALIZATION;

ADENOCARCINOMA; APPENDICEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 77951240814     PISSN: 17437555     EISSN: 17437563     Source Type: Journal    
DOI: 10.1111/j.1743-7563.2010.01276.x     Document Type: Article

References (31)

1. Berger A. Ein Fall von Krebs des Wurmfortsatzes. Ber Klin Wochenschr 1882, 19:610.
2. McCusker ME, Cote TR, Clegg LX, Sobin LH. Primary malignant neoplasms of the appendix: a population-based study from the surveillance, epidemiology and end-results program, 1973-1998. Cancer 2002, 94:3307-12.
3. O'Donnell ME, Badger SA, Beattie GC, Carson J, Garstin WI. Malignant neoplasms of the appendix. Int J Colorectal Dis 2007, 22:1239-48.
4. Connor SJ, Hanna GB, Frizelle FA. Appendiceal tumors: retrospective clinicopathologic analysis of appendiceal tumors from 7970 appendectomies. Dis Colon Rectum 1998, 41:75-80.
5. McGory ML, Maggard MA, Kang H, O'Connell JB, Ko CY. Malignancies of the appendix: beyond case series reports. Dis Colon Rectum 2005, 48:2264-71.
6. Smeenk RM, van Velthuysen ML, Verwaal VJ, Zoetmulder FA. Appendiceal neoplasms and pseudomyxoma peritonei: a population based study. Eur J Surg Oncol 2008, 34:196-201.
7. Misdraji J, Young RH. Primary epithelial neoplasms and other epithelial lesions of the appendix (excluding carcinoid tumors). Semin Diagn Pathol 2004, 21:120-33.
8. Pai RK, Longacre TA. Appendiceal mucinous tumors and pseudomyxoma peritonei: histologic features, diagnostic problems, and proposed classification. Adv Anat Pathol 2005, 12:291-311.
9. Hananel N, Powsner E, Wolloch Y. Adenocarcinoma of the appendix: an unusual disease. Eur J Surg 1998, 164:859-62.
10. Carr NJ, McCarthy WF, Sobin LH. Epithelial noncarcinoid tumors and tumor-like lesions of the appendix. A clinicopathologic study of 184 patients with a multivariate analysis of prognostic factors. Cancer 1995, 75:757-68.
11. O'Donnell ME, Carson J, Garstin WI. Surgical treatment of malignant carcinoid tumours of the appendix. Int J Clin Pract 2007, 61:431-7.
12. Nitecki SS, Wolff BG, Schlinkert R, Sarr MG. The natural history of surgically treated primary adenocarcinoma of the appendix. Ann Surg 1994, 219:51-7.
13. Murphy EM, Farquharson SM, Moran BJ. Management of an unexpected appendiceal neoplasm. Br J Surg 2006, 93:783-92.
14. Sugarbaker PH. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol 2006, 7:69-76.
15. Yan TD, Bijelic L, Sugarbaker PH. Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms. Ann Surg Oncol 2007, 14:2289-99.
16. Baratti D, Kusamura S, Nonaka D. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol 2008, 15:526-34.
17. Gough DB, Donohue JH, Schutt AJ. Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach. Ann Surg 1994, 219:112-19.
18. Deraco M, Baratti D, Inglese MG. Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei. Ann Surg Oncol 2004, 11:393-8.
19. Sugarbaker PH. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome. Eur J Surg Oncol 2001, 27:239-43.
20. Gonzalez-Moreno S, Sugarbaker PH. Right hemicolectomy does not confer a survival advantage in patients with mucinous carcinoma of the appendix and peritoneal seeding. Br J Surg 2004, 91:304-11.
21. Sugarbaker PH, Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 1999, 6:727-31.
22. Ko YH, Jung CK, Oh SN. Primary signet ring cell carcinoma of the appendix: a rare case report and our 18-year experience. World J Gastroenterol 2008, 14:5763-8.
23. Gonzalez-Moreno S, Brun E, Sugarbaker PH. Lymph node metastasis in epithelial malignancies of the appendix with peritoneal dissemination does not reduce survival in patients treated by cytoreductive surgery and perioperative intraperitoneal chemotherapy. Ann Surg Oncol 2005, 12:72-80.
24. Sugarbaker PH. Cytoreductive surgery and intraperitoneal chemotherapy with peritoneal spread of cystadenocarcinoma. Eur J Surg Suppl 1991, 561):75-82.
25. Glehen O, Kwiatkowski F, Sugarbaker PH. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 2004, 22:3284-92.
26. Hesketh KT. The management of primary adenocarcinoma of the vermiform appendix. Gut 1963, 4:158-68.
27. Andersson A, Bergdahl L, Boquist L. Primary carcinoma of the appendix. Ann Surg 1976, 183:53-7.
28. Ishibashi K, Sobajima J, Okada N. [A case of pseudomyxoma peritonei successfully treated with multidisciplinary treatment including modified FOLFOX6 regimen]. Gan Kagaku Ryoho 2007, 34:2047-9. In Japanese
29. Perrais M, Pigny P, Copin MC, Aubert JP, Van Seuningen I. Induction of MUC2 and MUC5AC mucins by factors of the epidermal growth factor (EGF) family is mediated by EGF receptor/Ras/Raf/extracellular signal-regulated kinase cascade and Sp1. J Biol Chem 2002, 277:32258-67.
30. Andreopoulou E, Safa M, Escalon J. Phase II study of cetuximab in mucinous peritoneal carcinomatosis. J Clin Oncol 2006, 24:14020. ASCO Annual Meeting Proceedings Part I. No. 18S (June 20 Supple
31. Logan-Collins JM, Lowy AM, Robinson-Smith TM. VEGF expression predicts survival in patients with peritoneal surface metastases from mucinous adenocarcinoma of the appendix and colon. Ann Surg Oncol 2008, 15:738-44.